Beyfortus 50 MG/0.5 ML syringe 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FQU4Z
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $56,940
Award facts
- Contract value 100% obligated
- $56,939.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $56,939.59 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Beyfortus 50 mg/0.5 mL syringes on January 14, 2026, with an ultimate completion date of January 15, 2026. This competitively awarded contract, which carries no set-aside designation, will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Beyfortus is a monoclonal antibody immunization used for respiratory syncytial virus (RSV) prevention in infants and young children, representing a critical pharmaceutical commodity for military healthcare operations.
This delivery order is issued under AmerisourceBergen Drug Corp's parent company, Cencora, Inc. (formerly AmerisourceBergen), which holds a substantial $999,999,999.00 indefinite delivery contract with the DLA Troop Support Medical through December 31, 2031. This primary vehicle enables the supply of an extensive range of pharmaceutical products, specialty medications, vaccines, and medical supplies to support military healthcare programs globally, including the Defense Health Agency and other federal medical institutions. The contract structure and awardee's established federal procurement track record demonstrate its capability to fulfill critical medical supply requirements for the Department of Defense healthcare system.
Quick answers
Who was awarded contract SPE2DR26FQU4Z?
SPE2DR26FQU4Z was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26FQU4Z worth?
The government has obligated $56,940 on SPE2DR26FQU4Z.
Is contract SPE2DR26FQU4Z an order under another contract?
Yes. SPE2DR26FQU4Z is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQU4Z competed?
The extent of competition for SPE2DR26FQU4Z was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award